Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPX-04 in papulopustular rosacea
NCT03050086Phase 2Completed
- Sponsor
- BioPharmX
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zilxi in papulopustular rosacea, sponsored by BioPharmX. Started Mar 2017; status: completed.
02
Drugs
zilxi
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT03050086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050086.